MMP3 and colitis: Kobayashi et al. identified MMP-3 and -10 belonging to the same subgroup of stromelysins as the major contributors to drug-induced colitis, on the basis of their inhibition by siRNA or blocking of the signaling pathways, resulting in effectively reduced severity of colitis [164].